Skip to main navigation Skip to search Skip to main content

A phase lll study of 1311 metaiodobenzylguanidine (1311-MIBG) or critzotinib added to intensive therapy for children with newly diagnosed high risk neuroblastoma (NBL)

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date01/1/22 → 12/31/26

Funding

  • Public Health Institute: $1.00